1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Turnstone Biologics Acquires Myst Therapeutics

M&A Deal Summary

Turnstone Biologics Acquires Myst Therapeutics

On January 20, 2021, Turnstone Biologics acquired life science company Myst Therapeutics

Acquisition Highlights
  • This is Turnstone Biologics’ 1st transaction in the Life Science sector.
  • This is Turnstone Biologics’ 1st transaction in the United States.
  • This is Turnstone Biologics’ 1st transaction in California.

M&A Deal Summary
Date 2021-01-20
Target Myst Therapeutics
Sector Life Science
Buyer(s) Turnstone Biologics
Deal Type Add-on Acquisition

Target

Myst Therapeutics

Los Angeles, California, United States
Myst Therapeutics, Inc. is a biotechnology company focused on advancing novel T-cell therapies for solid tumors. Myst Therapeutics is pursuing the development of an adoptive cell therapy utilizing enriched T cells from tumors and peripheral blood that target a broad spectrum of cancer mutations. Myst Therapeutics is based in Los Angeles, California.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Turnstone Biologics

Ottawa, Ontario, Canada
Category Company
Founded 2015
Sector Life Science
DESCRIPTION

Turnstone Biologics is a clinical-stage biotech company, is developing breakthrough cancer immunotherapies by advancing two leading and complementary platforms that drive innate and adaptive tumor immunity, to provide benefit to the millions of cancer patients underserved by current treatment options. Turnstone Biologics was founded in 2015 and is based in Ottawa, Ontario.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal